BCL2 and acute myeloid leukemia: A study conducted by Chan et al. revealed that BCL-2 inhibitor ABT-199 combined with IDH mutations have considerable effects on AML treatment, it is yet another example of SL through mitochondrial metabolism.100 Except for the TCA cycle, glycolysis is another indispensable process and feasible target related to the mitochondria.